|
Lebrikizumab Improves Lung Function in Asthma
Medscape August 4, 2011 — Treatment with the anti-interleukin-13 antibody lebrikizumab was associated with a significant improvement in lung function at week 12 compared to baseline in patients with poorly controlled asthma, according to the findings of a … Researchers find potential new treatment for asthma sufferers Lebrikizumab Ups Lung Function in Adults With Asthma IL-13 Blocker Helps Asthma Control |
View full post on asthma – Google News